Inc42 Daily Brief
Stay Ahead With Daily News & Analysis on India’s Tech & Startup Economy
Mumbai-based health care technology platform focused on alternate medicine, Welcome Cure, has raised $6 Mn (about INR 40 Cr) in pre-series A round of funding from two angel investors.
According to sources, the company raised the amount in two tranches. $1 Mn was raised from high net-worth individuals and $5 Mn from one of India’s largest media house.
With the newly raised capital, Welcome Cure plans to utilize it for marketing and expansion activities
Welcome Cure was started in 2014 by Dr. Jawahar J. Shah, an award-winning homeopathic practitioner, technocrat, educationalist and academician; and Punit Desai, an entrepreneur with vast experience, investments and capabilities in solar power, ecommerce & home shopping, films, media and entertainment sectors.
Welcome Cure is a virtual clinic that offers modern healthcare facilities of online consultation via video chat, live chat, Skype, telephonic and email interactions with expert physicians worldwide, at consumer’s convenience.
The startup boasts of a network of over 100 world class renowned doctors registered from across the globe, providing unlimited treatment for over 100 diseases under one digital roof.
The site also offers pocket-friendly health packages varying from three months to 24 months within the range of INR 3500 to INR 16,000, respectively. The portal offers end to end online homeopathy solution through the web and mobile application.
Punit Desai, co-founder of Welcome Cure said, “In a short span of time, we have received an overwhelming response from our users with a high renewal rate of close to 69%. We get consumer traction from various regions globally and have developed the entire technology in-house over a period of 24 months.”
Welcome Cure also has plans for another fund-raise in next three to six months in order to scale higher.
{{#name}}{{name}}{{/name}}{{^name}}-{{/name}}
{{#description}}{{description}}...{{/description}}{{^description}}-{{/description}}
Note: We at Inc42 take our ethics very seriously. More information about it can be found here.